...
首页> 外文期刊>American Journal of Dermatopathology >A Challenging Cutaneous T-Cell Lymphoma
【24h】

A Challenging Cutaneous T-Cell Lymphoma

机译:具挑战性的皮肤T细胞淋巴瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Cutaneous peripheral T-cell lymphomas not otherwise specified (CPTL-NOS) are rare neoplasms accounting for just 2% of cutaneous peripheral T-cell lymphomas (CPTL). Only very few case series have been reported. They represent a phenotypically and prognostically heterogenous group of CPTL that do not fit into any of CPTL well-defined subtypes. The authors report a case of a 64-year-old man with simultaneous plaque-like lesions and disseminated nodules growing rapidly on the face, trunk, and extremities over a 6-month period. There was no a history of preceding patches, erythematous plaques, rash, or pruritic lesions. These lesions were extending over 80% of the skin surface. Histopathologic analysis revealed dense diffuse infiltrates composed of mostly medium-sized to large lymphoid cells throughout the entire dermis without epidermotropism. Neoplastic cells were atypical with markedly pleomorphic nuclei. Immunohistochemistry showed that the tumor cells were positive for CD3, CD4, and CD5 with a loss of CD7. They were negative for CD20, CD8, CD56, CXCL13, PD1, TIA-1, granzyme-B, perforin, CD25, and CD30. The proliferative fraction was low, with MIB-1 labeling less than 10% of cells. The authors diagnosed the patient with primary CPTL-NOS. Despite the rarity of these tumors, clinicians as well as dermatopathologists and pathologists should be familiar with these rare CPTL especially because most of these lymphomas have an aggressive behavior and exhibit an unfavorable prognosis.
机译:皮肤周围性T细胞淋巴瘤(CPTL-NOS)没有特别说明,是罕见的肿瘤,仅占皮肤周围性T细胞淋巴瘤(CPTL)的2%。仅报道了很少的病例系列。它们代表了CPTL的表型和预后异质组,不适合任何CPTL定义明确的亚型。作者报告了一例64岁男性,同时出现斑块样病变,并且散布的结节在6个月内迅速在面部,躯干和四肢生长。没有既往斑块,红斑,皮疹或瘙痒性病变的病史。这些病变遍布皮肤表面的80%。组织病理学分析显示,在整个真皮中,致密弥漫性浸润大部分由中型至大型淋巴样细胞组成,无表皮性。肿瘤细胞是非典型的,具有明显的多形核。免疫组织化学显示,肿瘤细胞对CD3,CD4和CD5呈阳性,而CD7缺失。它们对CD20,CD8,CD56,CXCL13,PD1,TIA-1,粒酶B,穿孔素,CD25和CD30呈阴性。增殖分数很低,MIB-1标记的细胞不到10%。作者诊断出患者患有原发性CPTL-NOS。尽管这些肿瘤非常罕见,但临床医生以及皮肤病理学家和病理学家应熟悉这些罕见的CPTL,尤其是因为这些淋巴瘤大多数都具有侵袭性行为且预后不良。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号